ClinicalTrials.gg
Sign In

Gait Disorders, Neurologic clinical trials

The registry lists 346 studies for Gait Disorders, Neurologic across more than 10 countries. 54 are recruiting or about to start. 111 of them are mainly about Gait Disorders, Neurologic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Gait Disorders, Neurologic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
205
Status unknown
51
Recruiting
36
Active, not recruiting
17
Not yet recruiting
12
Terminated
11

Phase

Phase 2
6
Phase 1
5
Phase 4
4
Phase 3
1

Where

United States
77
Turkey
42
Italy
25
France
22
Switzerland
16
Spain
13

Who runs them

Hacettepe University (10) · Yonsei University (5) · Samsung Medical Center (5) · University of Sao Paulo General Hospital (4) · I.R.C.C.S. Fondazione Santa Lucia (4) · National Taiwan University Hospital (4) · Hangang Sacred Heart Hospital (4) · Karolinska Institutet (4)

What is being tested here

Drugs under test in Gait Disorders, Neurologic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Testosterone enanthate101
Testosterone101
Methylphenidate002
Memantine001
Botulinum toxin type A001
Ropivacaine001
Droxidopa001

Coming up

0phase 3 studies under way
12studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 36 Gait Disorders, Neurologic studies recruiting now, 14 (39%) set no upper age limit and 19 (53%) stop at 75 or younger. 5 (14%) take children under 18. 0 (0%) are for women only and 1 (3%) for men only; 5 (14%) take healthy volunteers.

Recruiting studies that take each age, of 36
AgeWomenMen
105 (14%)5 (14%)
1826 (72%)27 (75%)
3026 (72%)27 (75%)
4027 (75%)28 (78%)
5029 (81%)30 (83%)
6530 (83%)31 (86%)
7522 (61%)23 (64%)
8513 (36%)14 (39%)

Across all 346 studies, recruiting or not: 36% stop at 75 or younger and 24% at 65; 21% take children; 1% are for women only and 2% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Gait Disorders, Neurologic studies take

Of 197 interventional studies with no phase under Gait Disorders, Neurologic, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase14 mo5–38 · 197 studies—16 mo6–38 · 184 studies
Observational17 mo3–46 · 46 studies—18 mo3–46 · 45 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Results posted1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 346. Browse all 346 → or search them.